Health X Platform Q1 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹921 Cr
- ROE
- 0.44%
- Price to sales
- 0.63
- Debt to equity
- 0.04
- 52W high / low
- ₹375 / ₹252
- Sales growth (5Y)
- 20.08%
- EBITDA margin
- -4.53%
- Net profit margin
- 0.02%
- Promoter holding
- 74.07%
- Sales (last year)
- ₹1,468 Cr
Incorporated in 1989, Sastasundar Ventures Ltd is in the business of digital network of healthcare and portfolio management services[1]
Guidance scorecard · Q1 FY27 call
What Health X Platform Ltd's management guided
and where it ranks in Healthcare Services
Healthcare Services
RevenueQ1 FY27 call
40%+- July monthly revenue stood at INR 150+ crores, indicating strong growth momentum.
- Expansion into new regions including Odisha, Jharkhand, Bihar, Chhattisgarh, Haryana, UP, Rajasthan, and Northeast India; Northeast shows highest growth.
- Target to double market share in West Bengal from current 3-4% to about 7% over next 2-3 years.
- Growing JITO private label sales rapidly (from INR 25 lakhs to INR 79 lakhs recently), expected to significantly contribute to revenue and gross margin expansion.
- RetailerShakti business focusing on increasing wallet share per retailer, aiming to double it through AI-enabled Retail Air platform launching next quarter.
- Ongoing build-out of warehouses in key geographies to support increased capacity and faster delivery.
2 more points from Health X Platform Ltd's call on revenue
Create a free account to keep reading this call
MarginsQ1 FY27 call
Up 2%+See what Health X Platform Ltd said on margins — free account, 30 seconds.
CapexQ1 FY27 call
Planned- Health X is focused on owning its entire logistics and fulfillment centers instead of relying on outside warehouses, making it a USP.
- Existing fulfillment center capacity is running at about 90%, with an "existing plus" sideway extension planned to cover 50%-100% more revenue growth, supporting up to INR 3,000 crores revenue.
- Beyond this, massive infrastructure development is planned to build seamless large-scale capabilities.
- New warehouse capabilities are under construction in multiple locations: Noida (completed), West Bengal (partly done), Guwahati (under construction), Udaipur (started), and planned starts in Patna and Lucknow within 2-3 months.
- Capex plans include shifting from rented warehouses to owned facilities, prioritizing Guwahati.
2 more points from Health X Platform Ltd's call on capex
Create a free account to keep reading this call
FundraisingQ1 FY27 call
See what Health X Platform Ltd said on fundraising — free account, 30 seconds.
Order bookQ1 FY27 call
Rising- RetailerShakti serves approximately 75,000 retail pharmacies with 50,000+ SKUs.
- Monthly revenue in July (Q1 FY27) crossed INR 150 crores (subject to audit).
- RetailerShakti grew 48% year-on-year; SastaSundar grew 44% year-on-year.
- 69.4% of RetailerShakti business comes from orders above INR 2,500; 42.4% from orders above INR 5,000.
2 more points from Health X Platform Ltd's call on the order book
Create a free account to keep reading this call
Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- 1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Healthcare Services companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | Health X PlatformThis stock | 40%+ | Up 2%+ | ₹903 Cr | — |
| 2 | 40%+ | Flat | ₹583 Cr | 22.2 | |
| 3 | Aster DM Quality Care Ltd | 20–40% | Up 2%+ | ₹58,782 Cr | 162.9 |
| 4 | 20–40% | Up 0–2% | ₹1,730 Cr | 17.5 | |
| 5 | 20–40% | Up 0–2% | ₹580 Cr | 11.9 | |
| 6 | 20–40% | Flat | ₹1.13L Cr | 53.9 |
Sign up free to see every company in the sector ranking and track Health X Platform Ltd.
Pro shows every company guiding 40%+ revenue growth →Full Healthcare Services rankingFinancials of Health X Platform Ltd
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Health X Platform Ltd
Quarterly Results
Quarter-by-quarter operating performance
| Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 280.63 | 313.15 | 336.05 | 358.49 | 374.50 | 306.67 | 270.29 | 273.53 | 281.29 | 285.84 | 298.43 | 301.32 | 345.74 |
| Expenses + | 290.71 | 324.32 | 326.79 | 355.12 | 371.07 | 317.32 | 272.69 | 278.25 | 304.99 | 311.04 | 292.37 | 323.93 | 356.10 |
| Operating Profit | -10.08 | -11.17 | 9.26 | 3.37 | 3.43 | -10.65 | -2.40 | -4.72 | -23.70 | -25.20 | 6.06 | -22.61 | -10.36 |
| OPM % | -3.59% | -3.57% | 2.76% | 0.94% | 0.92% | -3.47% | -0.89% | -1.73% | -8.43% | -8.82% | 2.03% | -7.50% | -3.00% |
| Other Income + | 4.01 | 8.63 | 12.11 | 9.71 | 20.13 | 18.46 | 28.75 | -167.39 | -14.06 | 21.91 | 25.38 | 5.34 | 13.62 |
| Interest | 0.27 | 0.26 | 0.25 | 0.24 | 0.24 | 0.27 | 0.10 | 0.06 | 0.05 | 0.01 | 0.09 | 0.04 | 0.17 |
| Depreciation | 2.40 | 2.80 | 2.09 | 2.20 | 2.31 | 2.53 | 1.61 | 1.45 | 1.43 | 1.34 | 1.17 | 1.33 | 2.17 |
| Profit before tax | -8.74 | -5.60 | 19.03 | 10.64 | 21.01 | 5.01 | 24.64 | -173.62 | -39.24 | -4.64 | 30.18 | -18.64 | 0.92 |
| Tax % | -70.48% | 287.50% | -28.85% | -23.03% | 3.86% | -583.03% | -102.80% | -13.17% | 1.99% | -478.45% | 11.90% | -17.17% | 59.78% |
| Net Profit + | -26.37 | -48.00 | -0.28 | -12.20 | -3.23 | 21.58 | 40.96 | -154.78 | -37.80 | 17.57 | 26.59 | -15.44 | 0.37 |
| EPS in Rs | -6.00 | -10.75 | 0.41 | -2.55 | -0.24 | 5.17 | 9.79 | -34.39 | -8.47 | 4.30 | 7.52 | -3.99 | 0.36 |
Financials of Health X Platform Ltd
Profit & Loss
Annual income statement trend
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 30 | 52 | 89 | 135 | 162 | 222 | 388 | 551 | 1,798 | 1,060 | 1,432 | 1,159 | 1,231 |
| Expenses + | 35 | 62 | 116 | 155 | 175 | 255 | 440 | 561 | 684 | 1,168 | 1,456 | 1,177 | 1,283 |
| Operating Profit | -4 | -10 | -28 | -20 | -13 | -33 | -52 | -10 | 1,114 | -107 | -24 | -19 | -52 |
| OPM % | -15% | -19% | -31% | -15% | -8% | -15% | -13% | -2% | 62% | -10% | -2% | -2% | -4% |
| Other Income + | 0 | 2 | -0 | 2 | 7 | 0 | 1 | 1 | 3 | -5 | 4 | -179 | 66 |
| Interest | 1 | 1 | 2 | 3 | 1 | 3 | 1 | 3 | 3 | 2 | 1 | 0 | 0 |
| Depreciation | 2 | 6 | 7 | 7 | 6 | 6 | 5 | 4 | 4 | 8 | 9 | 6 | 6 |
| Profit before tax | -7 | -15 | -37 | -28 | -12 | -42 | -58 | -16 | 1,109 | -122 | -30 | -204 | 8 |
| Tax % | -5% | -0% | -1% | 2% | 19% | 3% | -9% | 4% | 22% | -19% | -119% | -34% | |
| Net Profit + | -6 | -15 | -37 | -29 | -15 | -43 | -52 | -17 | 865 | -99 | 6 | -134 | 29 |
| EPS in Rs | -2.03 | -4.68 | -11.51 | -9.00 | -3.73 | -11.81 | -12.19 | -3.27 | 197.05 | -22.70 | 2.79 | -28.66 | 8.19 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Health X Platform Ltd
Balance Sheet
Capital structure and asset base
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
| Reserves | 238 | 223 | 186 | 163 | 144 | 111 | 178 | 168 | 795 | 722 | 731 | 638 | 650 |
| Borrowings + | 0 | 5 | 19 | 21 | 12 | 2 | 8 | 12 | 2 | 9 | 4 | 1 | 5 |
| Other Liabilities + | 39 | 22 | 20 | 35 | 48 | 86 | 98 | 80 | 449 | 441 | 383 | 300 | 321 |
| Total Liabilities | 309 | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,149 | 970 | 1,008 |
| Fixed Assets + | 117 | 137 | 126 | 125 | 117 | 116 | 114 | 110 | 93 | 107 | 110 | 102 | 117 |
| CWIP | 0 | 3 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 10 | 1 |
| Investments | 41 | 22 | 10 | 17 | 46 | 36 | 56 | 43 | 666 | 513 | 676 | 575 | 633 |
| Other Assets + | 151 | 119 | 120 | 110 | 71 | 77 | 146 | 139 | 518 | 583 | 363 | 283 | 257 |
| Total Assets | 309 | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,149 | 970 | 1,008 |
Financials of Health X Platform Ltd
Cash Flows
Operating, investing and financing cash movement
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 36 | -12 | -12 | -2 | -49 | -30 | -69 | -31 | -207 | -112 | 36 | -17 |
| Cash from Investing Activity + | -42 | 7 | -1 | 4 | 15 | -2 | -22 | 21 | 220 | 133 | -34 | -1 |
| Cash from Financing Activity + | -3 | 4 | 13 | 5 | 33 | 26 | 103 | 4 | -11 | -2 | -2 | -0 |
| Net Cash Flow | -10 | -1 | -0 | 7 | -2 | -6 | 11 | -5 | 1 | 19 | -0 | -19 |
| Free Cash Flow | 15 | -28 | -18 | -0 | -55 | -33 | -71 | -31 | -212 | -128 | 22 | -27 |
| CFO/OP | -845% | 106% | 43% | 17% | 377% | 89% | 133% | 288% | -8% | 104% | -172% | 68% |
Financials of Health X Platform Ltd
Ratios
Working capital efficiency and return ratios
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 169 | 87 | 34 | 52 | 9 | 13 | 14 | 9 | 4 | 12 | 9 | 3 |
| Inventory Days | 337 | 91 | 80 | 73 | 59 | 77 | 57 | 71 | 69 | 34 | 40 | |
| Days Payable | 165 | 38 | 69 | 24 | 26 | 50 | 29 | 21 | 22 | 13 | 21 | |
| Cash Conversion Cycle | 169 | 259 | 87 | 62 | 58 | 46 | 41 | 38 | 55 | 59 | 31 | 22 |
| Working Capital Days | 441 | 344 | 182 | 49 | 61 | 61 | 54 | 44 | 46 | 93 | 58 | 47 |
| ROCE % | -2% | -6% | -14% | -12% | -8% | -19% | -25% | -6% | -7% | -11% | -3% | -1% |
Guidance history
How Health X Platform Ltd's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q1 FY27 call → | 40%+ | Up 2%+ | Planned | — | Rising |
| Q3 FY26 call → | 20–40% | Flat | Planned | — | — |
| Q2 FY26 call → | 20–40% | Flat | Planned | — | Rising |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
27 out of 100 — Cooling
Over the past year its share price has done worse than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | −8.5% | 52% |
| Last 6 months | +5.4% | 63% |
| Last 3 months | −10.7% | 43% |
The price is 49.3% below its all-time high of ₹560.15 (7 Jan 2022). Stocks more than 20% below their peak have their score halved, so 55 became 27.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Health X Platform Ltd: 0.4 × 52 + 0.4 × 63 + 0.2 × 43 = 55, halved to 27 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 16 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What Health X Platform Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Rainbow Childrens Medicare Ltd (Q2 FY27)
Year-on-year (YoY) growth in revenue: 23.2% . Key investor presentation takeaways from Rainbow Childrens Medicare Ltd's Q2 FY27 investor presentation — and how
- Narayana Hrudayalaya Ltd (Q2 FY27)
Consolidated operating revenue for Q2 FY27: ₹28,440 Mn, up 73.0% YoY (Page 15, 16). Key investor presentation takeaways from Narayana Hrudayalaya Ltd's Q2 FY27
- Artemis Medicare Services Ltd (Q2 FY27)
Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY (Page 39, 40, 20). Key investor presentation takeaways from Artemis Medicare Service
- Max Healthcare Institute Ltd (Q2 FY27)
Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY (Page 4, 17) . Key investor presentation takeaways from Max Healthcare Institute Ltd's Q2 FY27 investor presentatio